Two years after facing criticism that its clinical trials office was in “profound disarray,” UC San Diego Moores Cancer Center is pursuing renewal of a key federal grant with confidence, its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback